Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
Strength Training Burns More Fat Than Endurance Exercise in HIV
New Anti-HIV Drug Target Discovered
A 'Functional Cure' for HIV?
Changing the HIV Treatment Paradigm
HIV Treatment Diminishes Non-AIDS Illnesses
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Herpes Simplex Virus
Syphilis & Neurosyphilis
Shingles
The HIV Life Cycle
Human Papilloma Virus (HPV)
Treatments for Opportunistic Infections (OIs)
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

June 20, 2008

Crack Is Wack in Women’s HIV Study

HIV-positive women who regularly use crack cocaine are three times as likely as non-crack users to die of AIDS-related causes, even if they adhere to their prescribed antiretroviral (ARV) regimen, according to a multi-city study reported in the July 11 issue of AIDS. Infrequent users of crack cocaine are also more likely than nonusers to develop new AIDS-defining illnesses.

Despite numerous laboratory studies indicating that crack cocaine can have profound negative effects on immune system function, there have been very little data from studies involving people living with HIV, notably HIV-positive women, connecting the drug with more rapid disease progression. There has been one major study in HIV-positive male crack users.

The sobering confirmation comes from a study of 1,686 HIV-positive women enrolled at six U.S. clinics participating in the Women’s Interagency HIV Study (WIHS). According to the report, authored by Judith Cook, PhD, of the University of Illinois in Chicago and her WIHS colleagues, 80 percent of those enrolled were women of color, approximately 25 percent were infrequent (intermittent) crack users and approximately 3 percent were regular (persistent) crack users.

Between September 1996 and September 2004—years in which combination ARV therapy was available—there were 419 deaths, including 197 due to AIDS-related causes. Approximately 89 percent of the non-crack users and 90 percent of the infrequent crack users were alive eight years after entering the study, compared with 65 percent of the regular crack users. Even when the researchers factored in the length of time the women had been living with HIV, the effect of having a CD4 count below 200 upon entering the study, and the strictness with which the women adhered to their ARV therapy, the women regularly using crack were much more likely to be dead within eight years.

Rates of AIDS-related diseases, including bacterial pneumonia, pneumocystis pneumonia (PCP), herpes simplex virus, candidiasis, cryptosporidiosis, dementia, wasting syndrome and tuberculosis were higher—and developed much more rapidly—in crack users compared with non-users. Cook’s group also found that the time to a new AIDS-defining illness was significantly shorter among women using crack: 2,305 days for intermittent users and 2,211 days for persistent users, compared with 2,592 days for nonusers.

The authors also report that even during times in which regular and infrequent users of crack were abstaining from the drug, CD4 counts were lower and viral loads were higher, compared with the HIV-positive women who never used crack.

In conclusion, Cook’s team reiterates that theirs is the “first study to show that use of crack cocaine in a large, national cohort of HIV-positive women is…associated with subsequent deterioration in immune status, failure of virologic suppression, development of AIDS-defining conditions and [death] due to AIDS-related causes,” even among those who reported strict adherence to ARV therapy. “Likely confounds such as heroin use, injection-drug use, tobacco smoking, hepatitis C virus coinfection and depression do not appear to account for these significant associations,” they add. “Unlike prior research on a predominantly male sample, we did not consistently find that progression was less likely during periods of abstinence among female crack users, providing support for the notion that effects of cocaine on the immune system may vary by sex, as others have suggested.”

Search: crack cocaine, WIHS, women, Judith Cook, University of Illinois, bacterial pneumonia, pneumocystis pneumonia, PCP, herpes simplex virus, candidiasis, cryptosporidiosis, dementia, wasting syndrome, tuberculosis


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

comments 1 - 3 (of 3 total)    

mark holder, , 2008-06-24 08:12:16
very informative and educational as a poz ex user i never new the severity of the problem linked with crack. urz truly m.j.holder

David Evans, New York, AIDSmeds.com, 2008-06-23 10:24:25
John - the basic conclusion of this study is that crack use, even intermittent use, among HIV+ women can be seriously harmful to their health. It doesn't say that HIV has no role, which is a denialist argument, just that crack makes everything worse. BTW, the WIHS study is funded by the NIH, which has been at the forefront of fighting against the denialists for many years.

John, Washington D.C., 2008-06-21 22:06:28
Well, I am kind of suprised that AIDSMEDS would post this study. This study is obviously funded by AIDS denalists. Way to go AIDSMEDS.... you guys really let me down with this one. Are you guys being taken over by denaialists too?

comments 1 - 3 (of 3 total)    


[Go to top]

Get Started
Get Answers
I'm HIV positive. What's next?
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Conference Coverage

48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


CROI 2008
Boston, MA
February 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertise/contact us]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy